Antimicrobial resistance burden pre and post-COVID-19 pandemic with mapping the multidrug resistance in Egypt: a comparative cross-sectional study

  27 March 2024

The COVID-19 pandemic has led to an increase in antimicrobial resistance (AMR) in Egypt, with multidrug-resistant (MDR) and extensive drug-resistant (XDR) strains increasing. A multicenter study found that K. pneumoniae resistance has increased against quinolones and carbapenems, while E. coli resistance has increased against imipenem and meropenem. A. baumannii resistance has doubled against ceftazidime, cefepime, and piperacillin-tazobactam. MDR K. pneumoniae and A. baumannii resistance has also increased post-COVID-19. Urgent action is needed to mitigate this threat and preserve the country’s ability to face future infections.

Further reading: Nature Scientific Reports
Author(s): Shaimaa Abdelaziz Abdelmoneim et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed